Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024. In the quarter to June 2026, revenue grew 5.94%, EPS fell 25.3% and free cash flow grew 571.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.

76.71 2.13 −2.70%
Market cap
$10.6B
P/E
19.3×
Fwd P/E
20.3×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Revenue
789.61 759.85 826.42 769.05

+8 more quarters

Revenue Growth
5.94% 27.04% 25.73% 22.91%
Gross Profit
548.17 525.79 565.31 516.52
Operating Income
182.43 150.39 169.34 137.36
EBT
189.82 157.07 169.23 143.99
Income after Tax
151.57 124.30 140.59 118.97
Net Income Common
151.57 124.30 140.59 118.97
EPS (Diluted)
1.10 0.90 1.03 0.88
Shares (Diluted, Weighted)
137.38 138.19 137.06 135.39
Gross Margin
69.42% 69.20% 68.41% 67.16%
EBIT Margin
23.10% 19.79% 20.49% 17.86%
Net Profit Margin
19.20% 16.36% 17.01% 15.47%
EBITDA
251.93 220.24 245.31 215.39
EBIT
182.43 150.39 169.34 137.36

Show all line items

In millions of $ except per-share values · columns are period end dates